English
简体中文
Total: £ 56.28
Published Date: 2024-10-17 | Pages: 101 | Tables: 198 | Pharma & Healthcare
Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.
The global market for mRNA Drug was estimated to be worth US$ 396 million in 2023 and is forecast to a readjusted size of US$ 549.4 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for mRNA Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of mRNA Drug by region & country, by Type, and by Application.
The mRNA Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Drug.
Market Segmentation
By Company
Moderna
Pfizer
Zydus Cadila
Fosun Pharma
CureVAC
Sri Lankan Microorganisms
BioNtech
AstraZeneca
Janssen
Segment by Type:
Preventive Vaccines
Therapeutic Vaccine
Therapeutic Drugs
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of mRNA Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of mRNA Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of mRNA Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 mRNA Drug Product Introduction
1.2 Global mRNA Drug Market Size Forecast
1.2.1 Global mRNA Drug Sales Value (2019-2030)
1.2.2 Global mRNA Drug Sales Volume (2019-2030)
1.2.3 Global mRNA Drug Sales Price (2019-2030)
1.3 mRNA Drug Market Trends & Drivers
1.3.1 mRNA Drug Industry Trends
1.3.2 mRNA Drug Market Drivers & Opportunity
1.3.3 mRNA Drug Market Challenges
1.3.4 mRNA Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global mRNA Drug Players Revenue Ranking (2023)
2.2 Global mRNA Drug Revenue by Company (2019-2024)
2.3 Global mRNA Drug Players Sales Volume Ranking (2023)
2.4 Global mRNA Drug Sales Volume by Company Players (2019-2024)
2.5 Global mRNA Drug Average Price by Company (2019-2024)
2.6 Key Manufacturers mRNA Drug Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers mRNA Drug Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of mRNA Drug
2.9 mRNA Drug Market Competitive Analysis
2.9.1 mRNA Drug Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by mRNA Drug Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Drug as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Preventive Vaccines
3.1.2 Therapeutic Vaccine
3.1.3 Therapeutic Drugs
3.2 Global mRNA Drug Sales Value by Type
3.2.1 Global mRNA Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global mRNA Drug Sales Value, by Type (2019-2030)
3.2.3 Global mRNA Drug Sales Value, by Type (%) (2019-2030)
3.3 Global mRNA Drug Sales Volume by Type
3.3.1 Global mRNA Drug Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global mRNA Drug Sales Volume, by Type (2019-2030)
3.3.3 Global mRNA Drug Sales Volume, by Type (%) (2019-2030)
3.4 Global mRNA Drug Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global mRNA Drug Sales Value by Application
4.2.1 Global mRNA Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global mRNA Drug Sales Value, by Application (2019-2030)
4.2.3 Global mRNA Drug Sales Value, by Application (%) (2019-2030)
4.3 Global mRNA Drug Sales Volume by Application
4.3.1 Global mRNA Drug Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global mRNA Drug Sales Volume, by Application (2019-2030)
4.3.3 Global mRNA Drug Sales Volume, by Application (%) (2019-2030)
4.4 Global mRNA Drug Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global mRNA Drug Sales Value by Region
5.1.1 Global mRNA Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global mRNA Drug Sales Value by Region (2019-2024)
5.1.3 Global mRNA Drug Sales Value by Region (2025-2030)
5.1.4 Global mRNA Drug Sales Value by Region (%), (2019-2030)
5.2 Global mRNA Drug Sales Volume by Region
5.2.1 Global mRNA Drug Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global mRNA Drug Sales Volume by Region (2019-2024)
5.2.3 Global mRNA Drug Sales Volume by Region (2025-2030)
5.2.4 Global mRNA Drug Sales Volume by Region (%), (2019-2030)
5.3 Global mRNA Drug Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America mRNA Drug Sales Value, 2019-2030
5.4.2 North America mRNA Drug Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe mRNA Drug Sales Value, 2019-2030
5.5.2 Europe mRNA Drug Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific mRNA Drug Sales Value, 2019-2030
5.6.2 Asia Pacific mRNA Drug Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America mRNA Drug Sales Value, 2019-2030
5.7.2 South America mRNA Drug Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa mRNA Drug Sales Value, 2019-2030
5.8.2 Middle East & Africa mRNA Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions mRNA Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions mRNA Drug Sales Value
6.2.1 Key Countries/Regions mRNA Drug Sales Value, 2019-2030
6.2.2 Key Countries/Regions mRNA Drug Sales Volume, 2019-2030
6.3 United States
6.3.1 United States mRNA Drug Sales Value, 2019-2030
6.3.2 United States mRNA Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States mRNA Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe mRNA Drug Sales Value, 2019-2030
6.4.2 Europe mRNA Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe mRNA Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China mRNA Drug Sales Value, 2019-2030
6.5.2 China mRNA Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China mRNA Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan mRNA Drug Sales Value, 2019-2030
6.6.2 Japan mRNA Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan mRNA Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea mRNA Drug Sales Value, 2019-2030
6.7.2 South Korea mRNA Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea mRNA Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia mRNA Drug Sales Value, 2019-2030
6.8.2 Southeast Asia mRNA Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia mRNA Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India mRNA Drug Sales Value, 2019-2030
6.9.2 India mRNA Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India mRNA Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Moderna
7.1.1 Moderna Company Information
7.1.2 Moderna Introduction and Business Overview
7.1.3 Moderna mRNA Drug Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Moderna mRNA Drug Product Offerings
7.1.5 Moderna Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Information
7.2.2 Pfizer Introduction and Business Overview
7.2.3 Pfizer mRNA Drug Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Pfizer mRNA Drug Product Offerings
7.2.5 Pfizer Recent Development
7.3 Zydus Cadila
7.3.1 Zydus Cadila Company Information
7.3.2 Zydus Cadila Introduction and Business Overview
7.3.3 Zydus Cadila mRNA Drug Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Zydus Cadila mRNA Drug Product Offerings
7.3.5 Zydus Cadila Recent Development
7.4 Fosun Pharma
7.4.1 Fosun Pharma Company Information
7.4.2 Fosun Pharma Introduction and Business Overview
7.4.3 Fosun Pharma mRNA Drug Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Fosun Pharma mRNA Drug Product Offerings
7.4.5 Fosun Pharma Recent Development
7.5 CureVAC
7.5.1 CureVAC Company Information
7.5.2 CureVAC Introduction and Business Overview
7.5.3 CureVAC mRNA Drug Sales, Revenue and Gross Margin (2019-2024)
7.5.4 CureVAC mRNA Drug Product Offerings
7.5.5 CureVAC Recent Development
7.6 Sri Lankan Microorganisms
7.6.1 Sri Lankan Microorganisms Company Information
7.6.2 Sri Lankan Microorganisms Introduction and Business Overview
7.6.3 Sri Lankan Microorganisms mRNA Drug Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Sri Lankan Microorganisms mRNA Drug Product Offerings
7.6.5 Sri Lankan Microorganisms Recent Development
7.7 BioNtech
7.7.1 BioNtech Company Information
7.7.2 BioNtech Introduction and Business Overview
7.7.3 BioNtech mRNA Drug Sales, Revenue and Gross Margin (2019-2024)
7.7.4 BioNtech mRNA Drug Product Offerings
7.7.5 BioNtech Recent Development
7.8 AstraZeneca
7.8.1 AstraZeneca Company Information
7.8.2 AstraZeneca Introduction and Business Overview
7.8.3 AstraZeneca mRNA Drug Sales, Revenue and Gross Margin (2019-2024)
7.8.4 AstraZeneca mRNA Drug Product Offerings
7.8.5 AstraZeneca Recent Development
7.9 Janssen
7.9.1 Janssen Company Information
7.9.2 Janssen Introduction and Business Overview
7.9.3 Janssen mRNA Drug Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Janssen mRNA Drug Product Offerings
7.9.5 Janssen Recent Development
8 Industry Chain Analysis
8.1 mRNA Drug Industrial Chain
8.2 mRNA Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 mRNA Drug Sales Model
8.5.2 Sales Channel
8.5.3 mRNA Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. mRNA Drug Market Trends
Table 2. mRNA Drug Market Drivers & Opportunity
Table 3. mRNA Drug Market Challenges
Table 4. mRNA Drug Market Restraints
Table 5. Global mRNA Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global mRNA Drug Revenue Market Share by Company (2019-2024)
Table 7. Global mRNA Drug Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global mRNA Drug Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market mRNA Drug Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers mRNA Drug Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers mRNA Drug Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of mRNA Drug
Table 13. Global mRNA Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Drug as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global mRNA Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global mRNA Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global mRNA Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global mRNA Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global mRNA Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global mRNA Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global mRNA Drug Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global mRNA Drug Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global mRNA Drug Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global mRNA Drug Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global mRNA Drug Price by Type (2019-2024) & (US$/Unit)
Table 27. Global mRNA Drug Price by Type (2025-2030) & (US$/Unit)
Table 28. Global mRNA Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global mRNA Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global mRNA Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global mRNA Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global mRNA Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global mRNA Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global mRNA Drug Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global mRNA Drug Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global mRNA Drug Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global mRNA Drug Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global mRNA Drug Price by Application (2019-2024) & (US$/Unit)
Table 39. Global mRNA Drug Price by Application (2025-2030) & (US$/Unit)
Table 40. Global mRNA Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global mRNA Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global mRNA Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global mRNA Drug Sales Value by Region (2019-2024) & (%)
Table 44. Global mRNA Drug Sales Value by Region (2025-2030) & (%)
Table 45. Global mRNA Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global mRNA Drug Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global mRNA Drug Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global mRNA Drug Sales Volume by Region (2019-2024) & (%)
Table 49. Global mRNA Drug Sales Volume by Region (2025-2030) & (%)
Table 50. Global mRNA Drug Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global mRNA Drug Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions mRNA Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions mRNA Drug Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions mRNA Drug Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions mRNA Drug Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions mRNA Drug Sales Volume, (2025-2030) & (K Units)
Table 57. Moderna Company Information
Table 58. Moderna Introduction and Business Overview
Table 59. Moderna mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Moderna mRNA Drug Product Offerings
Table 61. Moderna Recent Development
Table 62. Pfizer Company Information
Table 63. Pfizer Introduction and Business Overview
Table 64. Pfizer mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Pfizer mRNA Drug Product Offerings
Table 66. Pfizer Recent Development
Table 67. Zydus Cadila Company Information
Table 68. Zydus Cadila Introduction and Business Overview
Table 69. Zydus Cadila mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Zydus Cadila mRNA Drug Product Offerings
Table 71. Zydus Cadila Recent Development
Table 72. Fosun Pharma Company Information
Table 73. Fosun Pharma Introduction and Business Overview
Table 74. Fosun Pharma mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Fosun Pharma mRNA Drug Product Offerings
Table 76. Fosun Pharma Recent Development
Table 77. CureVAC Company Information
Table 78. CureVAC Introduction and Business Overview
Table 79. CureVAC mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. CureVAC mRNA Drug Product Offerings
Table 81. CureVAC Recent Development
Table 82. Sri Lankan Microorganisms Company Information
Table 83. Sri Lankan Microorganisms Introduction and Business Overview
Table 84. Sri Lankan Microorganisms mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Sri Lankan Microorganisms mRNA Drug Product Offerings
Table 86. Sri Lankan Microorganisms Recent Development
Table 87. BioNtech Company Information
Table 88. BioNtech Introduction and Business Overview
Table 89. BioNtech mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. BioNtech mRNA Drug Product Offerings
Table 91. BioNtech Recent Development
Table 92. AstraZeneca Company Information
Table 93. AstraZeneca Introduction and Business Overview
Table 94. AstraZeneca mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. AstraZeneca mRNA Drug Product Offerings
Table 96. AstraZeneca Recent Development
Table 97. Janssen Company Information
Table 98. Janssen Introduction and Business Overview
Table 99. Janssen mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Janssen mRNA Drug Product Offerings
Table 101. Janssen Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. mRNA Drug Downstream Customers
Table 105. mRNA Drug Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. mRNA Drug Product Picture
Figure 2. Global mRNA Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global mRNA Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Global mRNA Drug Sales Volume (2019-2030) & (K Units)
Figure 5. Global mRNA Drug Sales Price (2019-2030) & (US$/Unit)
Figure 6. mRNA Drug Report Years Considered
Figure 7. Global mRNA Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global mRNA Drug Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by mRNA Drug Revenue in 2023
Figure 10. mRNA Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Preventive Vaccines Picture
Figure 12. Therapeutic Vaccine Picture
Figure 13. Therapeutic Drugs Picture
Figure 14. Global mRNA Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global mRNA Drug Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global mRNA Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global mRNA Drug Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global mRNA Drug Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Clinic
Figure 21. Global mRNA Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global mRNA Drug Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global mRNA Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global mRNA Drug Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global mRNA Drug Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America mRNA Drug Sales Value (2019-2030) & (US$ Million)
Figure 27. North America mRNA Drug Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe mRNA Drug Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe mRNA Drug Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific mRNA Drug Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific mRNA Drug Sales Value by Country (%), 2023 VS 2030
Figure 32. South America mRNA Drug Sales Value (2019-2030) & (US$ Million)
Figure 33. South America mRNA Drug Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa mRNA Drug Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa mRNA Drug Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions mRNA Drug Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions mRNA Drug Sales Volume (%), (2019-2030)
Figure 38. United States mRNA Drug Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States mRNA Drug Sales Value by Type (%), 2023 VS 2030
Figure 40. United States mRNA Drug Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe mRNA Drug Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe mRNA Drug Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe mRNA Drug Sales Value by Application (%), 2023 VS 2030
Figure 44. China mRNA Drug Sales Value, (2019-2030) & (US$ Million)
Figure 45. China mRNA Drug Sales Value by Type (%), 2023 VS 2030
Figure 46. China mRNA Drug Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan mRNA Drug Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan mRNA Drug Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan mRNA Drug Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea mRNA Drug Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea mRNA Drug Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea mRNA Drug Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia mRNA Drug Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia mRNA Drug Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia mRNA Drug Sales Value by Application (%), 2023 VS 2030
Figure 56. India mRNA Drug Sales Value, (2019-2030) & (US$ Million)
Figure 57. India mRNA Drug Sales Value by Type (%), 2023 VS 2030
Figure 58. India mRNA Drug Sales Value by Application (%), 2023 VS 2030
Figure 59. mRNA Drug Industrial Chain
Figure 60. mRNA Drug Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
